Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02607683 · ClinicalTrials.gov registry record · Phase 2
Phase 2b/3 Study of XAF5 Ointment for Steatoblepharon (Undereye Bags)
A Phase 2 study, sponsored by Topokine Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 300
- Enrollment target
NCT02607683 is a Phase 2 study that has completed, run by Topokine Therapeutics. The registered enrollment target is 300 participants.
The verdict
NCT02607683, a Phase 2 study, has completed, sponsored by Topokine Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 300 participants
- Enrollment target
Study Summary
This randomized, placebo-controlled, double-masked, Phase 2b/Phase 3 study will assess the efficacy of two different concentrations of XAF5 Ointment for reduction of lower lid steatoblepharon (undereye bags).
Interventions
- DRUG Matching placebo
- DRUG XAF5 (concentration A: 0.1%)
- DRUG XAF5 (concentration B: 0.035%)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2016-01-01 |
| Est. Completion | 2016-10-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02607683
The ClinicalTrials.gov registry entry for NCT02607683 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Topokine Therapeutics, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Matching placebo is the first listed.
NCT02607683 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02607683 about?
NCT02607683 is a clinical study titled "Phase 2b/3 Study of XAF5 Ointment for Steatoblepharon (Undereye Bags)". This randomized, placebo-controlled, double-masked, Phase 2b/Phase 3 study will assess the efficacy of two different concentrations of XAF5 Ointment for reduction of lower lid steatoblepharon (undereye bags).
What is the current status of trial NCT02607683?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 300 participants. The study started on 2016-01-01. Estimated completion is 2016-10-31.
What interventions are being tested in trial NCT02607683?
The interventions under investigation include: Matching placebo (DRUG), XAF5 (concentration A: 0.1%) (DRUG), XAF5 (concentration B: 0.035%) (DRUG).
Who is sponsoring clinical trial NCT02607683?
This trial is sponsored by Topokine Therapeutics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.